2nd Annual Oncology Market & Patient Access

Event overview:

This conference and networking event will present a fresh and original perspective on communicating the value and cost-effectiveness of high-value oncology drugs with payers, HTA assessors and other key stakeholders.

Unlike other general pricing & reimbursement meetings which broadly discuss many therapeutic areas, this event will be focused specifically on the oncology marketplace. This conference will look at the latest innovative market access techniques such as value-based pricing schemes, risk sharing, as well as satisfying HTA requirements to build the right dossier. All participants will experience real-life examples on how to deliver value to payers, as well as satisfying patient needs.

By bringing multi-stakeholder perspectives into one room, this meeting will provide a balanced picture of oncology health economics today. By meeting policy makers and top industry figures that are designing or deciding on pricing & reimbursement models, attendees would be in a much better position to implement more-successful market access strategies, but also to provide life-improving therapies to patients in need.

Why attend:

• Benchmark, network and co-operate with pharma & non-pharma decision makers.
• Get up to date on innovative reimbursement schemes and their implementation.
• Learn what data makes the difference for HTA agencies and payers and how to present it.
• Understand the best ways to communicate value and achieve maximum patient and market access.
• Hear multi-stakeholder perspectives from: pharmaceutical industry, academia, public insurers, HTA, policy makers, patient groups.
• Discover how payers are viewing risk-sharing and value-based pricing agreements and what are their initiatives in the field.
• Understand what patients want and what they view as quality treatment.

Who will benefit:

• Pharmaceutical companies:
  • Vice-Presidents, Directors, Managers involved in oncology: Pricing & Reimbursement, Health Economics & Outcomes, Government & Stakeholder Relations, Regulatory Affairs, Medical Affairs, Marketing, Therapy Area Heads, Market Access, Country Managers

• Solution providers & consultants:
  • CEOs, Business Development, Senior Consultants, Regional Heads

• Independent Academics, Health Economists, Senior Doctors, & Patient Representatives.

Prestigious speaker panel

A more detailed list of speakers’ names is available on the downloadable agenda. Please „request event agenda“ below.